查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1476331

到 2030 年射頻消融設備的全球市場預測：按產品、模式、應用、最終用戶和地區進行分析

Radiofrequency Ablation Devices Market Forecasts to 2030 - Global Analysis By Product, Modality, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球射頻消融設備市場規模為 48.7 億美元，預計到 2030 年將達到 114.1 億美元，預測期內複合年成長率為 12.9%。

射頻消融設備是醫療程序中使用的微創工具，用於治療慢性疼痛和心律不整等某些疾病。這些設備使用高頻電流產生熱量，直接作用於特定的組織和神經，有效地破壞它們。與傳統手術方法相比，RFA 手術因其準確性、微創性和恢復時間短而受到青睞。

根據世界衛生組織2021年全球衛生支出資料庫，德國將國內生產總值（GDP）的12.8%用於醫療保健，英國為11.9%，瑞典為11.3%，挪威為10.1%，義大利為9.5%。

慢性病增加

癌症和心血管疾病等慢性病的盛行率不斷上升，推動了對射頻消融設備的需求。這些設備提供了一種微創解決方案來治療與這些疾病相關的慢性疼痛和衰弱症狀。隨著人口老化和慢性病變得更加普遍，對有效治療方案的需求也隨之增加。射頻消融治療正在推動市場成長，因為它為患者提供了傳統手術的可行替代方案，從而縮短了住院時間、加快了康復時間並提高了生活品質。

併發症的風險

RFA 設備出現併發症的風險包括感染、神經損傷、出血，在極少數情況下還會損傷附近器官。這些併發症可能會損害患者的信心，由於額外的治療而增加醫療費用，並導致醫療保健提供者承擔法律責任。因此，安全問題可能會阻礙患者接受和醫生採用 RFA 程序。有限的採用將限制手術數量並減緩對 RFA 設備的需求，抑制市場成長，影響製造商的產生收入，並抑制市場擴張。

增加患者對微創手術的偏好

患者擴大尋求減少術後併發症、縮短恢復時間並儘量減少不適的手術。射頻消融為治療各種醫療狀況提供了傳統手術技術的微創替代方案，滿足了患者對微創選擇的需求。因此，隨著醫療保健提供者努力滿足患者對更方便、更安全且恢復時間更短的治療方法的偏好，射頻消融設備市場正在經歷成長。

與替代療法的競爭

射頻消融的替代治療方法包括藥物治療、物理治療和微創治療，例如冷凍解凍和雷射消融。此類替代療法的競爭可以為患者和醫療保健提供者提供管理病情的新選擇，從而減少需求。此外，一些替代療法比射頻消融具有更低的前期成本和更低的感知風險，這使得它們對某些患者和衛生系統更具吸引力，從而限制了射頻消融的市場潛力。

COVID-19 的影響

COVID-19 的爆發對射頻消融設備市場產生了各種影響。最初由於封鎖和限制而造成的中斷導致選擇性手術和設備銷售下降，但醫療服務的逐步恢復和微創治療的優先化正在支持市場的復甦。此外，此次疫情凸顯了微創治療對於最大程度地減少患者住院時間和減輕醫療保健系統負擔的重要性，從而有利於在後疫情時代進一步普及射頻消融術設備。

預計POLA市場在預測期內將是最大的

POLA市場預計將出現良好成長。這些設備是最先進的工具，用於微創手術治療各種醫療狀況。多極射頻消融術使用多個電極來創建更廣泛和受控的熱消融區域。該技術可以精確地瞄準組織，同時最大限度地減少對周圍區域的損害。多極射頻消融在肝癌、肺癌、慢性疼痛等治療中顯示出良好的效果。其多功能性和有效性使其成為現代介入放射學和腫瘤學實踐中的寶貴工具。

預計疼痛管理產業在預測期內複合年成長率最高

疼痛管理領域預計在預測期內將出現最高的複合年成長率，因為它為慢性疼痛提供微創緩解。這些設備使用射頻波來瞄準並惰性傳輸疼痛訊號的特定神經。 RFA 透過精確地瞄準神經而不損傷周圍組織，為手術和藥物治療提供了低風險的替代方案。由於其有效性、最短的恢復時間以及改善患者生活品質的能力，RFA 設備已成為疼痛管理領域的重要工具。

比最大的地區

由於慢性病盛行率不斷上升、醫療保健成本不斷上升以及對微創治療的認知不斷提高，預計亞太地區將在預測期內佔據最大的市場佔有率。中國、印度和日本等國家是這一成長的主要貢獻者，這得益於大量的患者群體和醫療保健服務的改善。此外，新興國家醫療保健基礎設施和技術採用的進步進一步推動了需求。

複合年成長率最高的地區：

由於先進的醫療基礎設施和有利的報銷政策，預計北美在預測期內將呈現最高的複合年成長率。美國由於其龐大的患者群體和在醫療保健研發方面的大量投資而在該地區市場佔據主導地位。技術的進步和微創手術的不斷採用進一步促進了市場的成長。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球射頻消融設備市場：按產品

  • 射頻消融術發生器
  • 射頻消融術導管
  • 射頻消融術探頭
  • 射頻消融術配件
  • 其他產品

第6章全球射頻消融設備市場：依方式分類

  • 單極結構
  • 雙極性
  • 多極

第7章全球射頻消融設備市場：依應用分類

  • 心臟病學
  • 腫瘤學
  • 疼痛管理
  • 婦科
  • 泌尿系統
  • 整形外科
  • 美麗
  • 其他用途

第8章全球射頻消融設備市場：依最終用戶分類

  • 醫院
  • 門診手術中心
  • 專科診所
  • 研究機構
  • 其他最終用戶

第9章全球射頻消融設備市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司概況

  • Medtronic PLC
  • Boston Scientific Corporation
  • Abbott Laboratories
  • AngioDynamics Inc.
  • Johnson & Johnson
  • Stryker Corporation
  • Merit Medical Systems Inc.
  • Royal Philips
  • Olympus Corporation
  • Hologic Inc.
  • Cosman Medical
  • RF Medical Corporation
  • Misonix Inc.
  • Neomed Management AS
  • Diros Technology Inc.
  • Compal Electronics
  • Smith & Nephew PLC
  • Elekta AB
  • CONMED Corporation
  • AtriCure
Product Code: SMRC25877

According to Stratistics MRC, the Global Radiofrequency Ablation Devices Market is accounted for $4.87 billion in 2023 and is expected to reach $11.41 billion by 2030 growing at a CAGR of 12.9% during the forecast period. Radiofrequency ablation devices are minimally invasive tools used in medical procedures to treat certain conditions like chronic pain or abnormal heart rhythms. These devices use high-frequency electrical currents to generate heat, which is directed to specific tissues or nerves, effectively destroying them. RFA procedures are often preferred for their precision, minimal invasiveness, and shorter recovery times compared to traditional surgical methods.

According to the WHO Global Health Expenditure Database 2021, Germany spent 12.8% of its Gross Domestic Product (GDP) on healthcare, the UK spent 11.9%, Sweden spent 11.3%, Norway spent 10.1%, and Italy spent 9.5%.

Market Dynamics:

Driver:

Rising incidences of chronic diseases

The increasing prevalence of chronic diseases, such as cancer and cardiovascular conditions, drives the demand for radiofrequency ablation devices. These devices offer minimally invasive solutions for treating chronic pain and debilitating symptoms associated with these diseases. As the aging population grows and chronic conditions become more prevalent, there is a heightened need for effective treatment options. Radiofrequency ablation procedures provide patients with a viable alternative to traditional surgery, leading to reduced hospital stays, faster recovery times, and improved quality of life, thus fueling market growth.

Restraint:

Risk of complications

The risks of complications in RFA devices include infection, nerve damage, bleeding, and rarely, damage to nearby organs. These complications can undermine patient confidence, increase healthcare costs due to additional treatments, and lead to legal liabilities for healthcare providers. Consequently, concerns regarding safety may deter patient acceptance and physician adoption of RFA procedures. Limited adoption hampers market growth by restraining procedure volumes and slowing the demand for RFA devices, impacting revenue generation for manufacturers and impeding market expansion.

Opportunity:

Growing patient preference for minimally invasive procedures

Patients increasingly seek procedures that offer reduced post-operative complications, quicker recovery times, and minimal discomfort. Radiofrequency ablation provides a minimally invasive alternative to traditional surgical methods for treating various medical conditions, fulfilling patient demand for less invasive options. As a result, the market for radiofrequency ablation devices experiences growth as healthcare providers strive to meet patient preferences for procedures that offer greater convenience, safety, and shorter recovery periods.

Threat:

Competition from alternative treatment options

Alternative treatment options to radiofrequency ablation devices include medication, physical therapy, and other minimally invasive procedures such as cryoablation and laser ablation. Competition from these alternatives offers patients and healthcare providers with additional choices for managing conditions, potentially diverting the demand. Additionally, some alternative treatments have lower upfront costs or perceived risks compared to radiofrequency ablation, making them more attractive options for certain patients or healthcare systems, thereby limiting the market potential for radiofrequency ablation devices.

Covid-19 Impact

The covid-19 pandemic has had a mixed impact on the radiofrequency ablation devices market. While the initial disruption caused by lockdowns and restrictions led to a decline in elective procedures and device sales, the gradual resumption of healthcare services and the prioritization of minimally invasive treatments have supported market recovery. Additionally, the pandemic has underscored the importance of less invasive procedures to minimize patient hospital stays and reduce the burden on healthcare systems, potentially driving further adoption of radiofrequency ablation devices in the post-pandemic era.

The multipolar segment is expected to be the largest during the forecast period

The multipolar segment is estimated to have a lucrative growth. These devices are cutting-edge tools used in minimally invasive procedures to treat various medical conditions. Multipolar RFA employs multiple electrodes to create a more extensive and controlled thermal ablation zone. This technology enables precise targeting of tissues while minimizing damage to surrounding areas. Multipolar RFA has shown promising results in treating conditions such as liver cancer, lung tumours, and chronic pain. Its versatility and efficacy make it a valuable tool in modern interventional radiology and oncology practices.

The pain management segment is expected to have the highest CAGR during the forecast period

The pain management segment is anticipated to witness the highest CAGR growth during the forecast period, due to its minimally invasive relief for chronic pain. These devices employ radiofrequency waves to target and deactivate specific nerves that transmit pain signals. By precisely targeting nerves without damaging surrounding tissue, RFA offers a low-risk alternative to surgery and medication. Its effectiveness, minimal recovery time, and ability to improve patients' quality of life make RFA devices indispensable tools in the field of pain management.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period due to increasing prevalence of chronic diseases, rising healthcare expenditure, and growing awareness about minimally invasive treatments. Countries like China, India, and Japan are key contributors to this growth, supported by a large patient population and improving access to healthcare services. Additionally, advancements in healthcare infrastructure and technology adoption in emerging economies further bolster demand.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to its advanced healthcare infrastructure, and favourable reimbursement policies. The United States dominates the region's market due to its large patient population and significant investments in healthcare R&D. Technological advancements and increasing adoption of minimally invasive procedures further contribute to market growth.

Key players in the market

Some of the key players profiled in the Radiofrequency Ablation Devices Market include Medtronic PLC, Boston Scientific Corporation, Abbott Laboratories, AngioDynamics Inc., Johnson & Johnson, Stryker Corporation, Merit Medical Systems Inc., Royal Philips, Olympus Corporation, Hologic Inc., Cosman Medical, RF Medical Corporation, Misonix Inc., Neomed Management AS, Diros Technology Inc., Compal Electronics, Smith & Nephew PLC, Elekta AB, CONMED Corporation and AtriCure.

Key Developments:

In April 2023, Taiwanese electronics company, Compal Electronics has expanded into the therapeutic medical device segment by introducing a new radiofrequency ablation (RFA) system called AblatePal. The new RFA system is intended for use in coagulation and ablation of soft tissue during percutaneous and intraoperative procedures, including partial or complete ablation of non-resectable liver lesions.

In April 2022, Royal Philips launched the latest release of its KODEX-EPD system, which offers enhanced imaging and mapping capabilities for RF ablation, including the new Tissue Engagement Viewer and support for Medtronic DiamondTemp ablation system.

Products Covered:

  • Radiofrequency Ablation Generators
  • Radiofrequency Ablation Catheters
  • Radiofrequency Ablation Probes
  • Radiofrequency Ablation Accessories
  • Other Products

Modalities Covered:

  • Unipolar
  • Bipolar
  • Multipolar

Applications Covered:

  • Cardiology
  • Oncology
  • Pain Management
  • Gynaecology
  • Urology
  • Orthopaedics
  • Cosmetology
  • Other Applications

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Radiofrequency Ablation Devices Market, By Product

  • 5.1 Introduction
  • 5.2 Radiofrequency Ablation Generators
  • 5.3 Radiofrequency Ablation Catheters
  • 5.4 Radiofrequency Ablation Probes
  • 5.5 Radiofrequency Ablation Accessories
  • 5.6 Other Products

6 Global Radiofrequency Ablation Devices Market, By Modality

  • 6.1 Introduction
  • 6.2 Unipolar
  • 6.3 Bipolar
  • 6.4 Multipolar

7 Global Radiofrequency Ablation Devices Market, By Application

  • 7.1 Introduction
  • 7.2 Cardiology
  • 7.3 Oncology
  • 7.4 Pain Management
  • 7.5 Gynaecology
  • 7.6 Urology
  • 7.7 Orthopaedics
  • 7.8 Cosmetology
  • 7.9 Other Applications

8 Global Radiofrequency Ablation Devices Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Ambulatory Surgical Centers
  • 8.4 Specialty Clinics
  • 8.5 Research Institutes
  • 8.6 Other End Users

9 Global Radiofrequency Ablation Devices Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Medtronic PLC
  • 11.2 Boston Scientific Corporation
  • 11.3 Abbott Laboratories
  • 11.4 AngioDynamics Inc.
  • 11.5 Johnson & Johnson
  • 11.6 Stryker Corporation
  • 11.7 Merit Medical Systems Inc.
  • 11.8 Royal Philips
  • 11.9 Olympus Corporation
  • 11.10 Hologic Inc.
  • 11.11 Cosman Medical
  • 11.12 RF Medical Corporation
  • 11.13 Misonix Inc.
  • 11.14 Neomed Management AS
  • 11.15 Diros Technology Inc.
  • 11.16 Compal Electronics
  • 11.17 Smith & Nephew PLC
  • 11.18 Elekta AB
  • 11.19 CONMED Corporation
  • 11.20 AtriCure

List of Tables

  • Table 1 Global Radiofrequency Ablation Devices Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Radiofrequency Ablation Devices Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Radiofrequency Ablation Devices Market Outlook, By Radiofrequency Ablation Generators (2021-2030) ($MN)
  • Table 4 Global Radiofrequency Ablation Devices Market Outlook, By Radiofrequency Ablation Catheters (2021-2030) ($MN)
  • Table 5 Global Radiofrequency Ablation Devices Market Outlook, By Radiofrequency Ablation Probes (2021-2030) ($MN)
  • Table 6 Global Radiofrequency Ablation Devices Market Outlook, By Radiofrequency Ablation Accessories (2021-2030) ($MN)
  • Table 7 Global Radiofrequency Ablation Devices Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 8 Global Radiofrequency Ablation Devices Market Outlook, By Modality (2021-2030) ($MN)
  • Table 9 Global Radiofrequency Ablation Devices Market Outlook, By Unipolar (2021-2030) ($MN)
  • Table 10 Global Radiofrequency Ablation Devices Market Outlook, By Bipolar (2021-2030) ($MN)
  • Table 11 Global Radiofrequency Ablation Devices Market Outlook, By Multipolar (2021-2030) ($MN)
  • Table 12 Global Radiofrequency Ablation Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 13 Global Radiofrequency Ablation Devices Market Outlook, By Cardiology (2021-2030) ($MN)
  • Table 14 Global Radiofrequency Ablation Devices Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 15 Global Radiofrequency Ablation Devices Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 16 Global Radiofrequency Ablation Devices Market Outlook, By Gynaecology (2021-2030) ($MN)
  • Table 17 Global Radiofrequency Ablation Devices Market Outlook, By Urology (2021-2030) ($MN)
  • Table 18 Global Radiofrequency Ablation Devices Market Outlook, By Orthopaedics (2021-2030) ($MN)
  • Table 19 Global Radiofrequency Ablation Devices Market Outlook, By Cosmetology (2021-2030) ($MN)
  • Table 20 Global Radiofrequency Ablation Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 21 Global Radiofrequency Ablation Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 22 Global Radiofrequency Ablation Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 23 Global Radiofrequency Ablation Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 24 Global Radiofrequency Ablation Devices Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 25 Global Radiofrequency Ablation Devices Market Outlook, By Research Institutes (2021-2030) ($MN)
  • Table 26 Global Radiofrequency Ablation Devices Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.